Stay updated on Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now includes a new revision entry v3.3.2, and the previous revision v3.3.1 has been removed.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page history now shows a new revision identifier (v3.3.1) and the prior revision (v3.2.0) removed, indicating a backend/UI update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the generic government funding/operating status notice from the page header. The study record now displays without that disclaimer.SummaryDifference0.6%

- Check43 days agoChange DetectedThe Record History page includes a new version entry and minor layout adjustments, with no changes to core study content, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, with links to official status pages. - Updated version to v3.2.0; removed prior v3.1.0.SummaryDifference11%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.